BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29169115)

  • 1. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
    Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
    Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.
    Chaiprasert T; Armartmuntree N; Techasen A; Sakonsinsiri C; Pinlaor S; Ungarreevittaya P; Khuntikeo N; Namwat N; Thanan R
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31284679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Insulin Receptor Substrate 1 (IRS1) Relates to Poor Prognosis and Promotes Proliferation, Stemness, Migration, and Oxidative Stress Resistance in Cholangiocarcinoma.
    Kaewlert W; Sakonsinsiri C; Lert-Itthiporn W; Ungarreevittaya P; Pairojkul C; Pinlaor S; Murata M; Thanan R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis.
    Thanan R; Techasen A; Hou B; Jamnongkan W; Armartmuntree N; Yongvanit P; Murata M
    Biochem Biophys Res Commun; 2015 Aug; 464(1):182-8. PubMed ID: 26100205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.
    Kaewlert W; Sakonsinsiri C; Namwat N; Sawanyawisuth K; Ungarreevittaya P; Khuntikeo N; Armartmuntree N; Thanan R
    Horm Cancer; 2018 Dec; 9(6):408-419. PubMed ID: 30284180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression.
    Armartmuntree N; Jusakul A; Sakonsinsiri C; Loilome W; Pinlaor S; Ungarreevittaya P; Yong CH; Techasen A; Imtawil K; Kraiklang R; Suwannakul N; Kaewlert W; Chaiprasert T; Thanan R; Murata M
    J Cancer; 2021; 12(9):2673-2686. PubMed ID: 33854627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
    Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
    Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
    Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis.
    Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
    Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
    Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
    PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
    Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
    World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.
    Jamnongkan W; Thanan R; Techasen A; Namwat N; Loilome W; Intarawichian P; Titapun A; Yongvanit P
    Tumour Biol; 2017 Jul; 39(7):1010428317717655. PubMed ID: 28671021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.